Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug
Article in Biomedicine & Pharmacotherapy (December 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (December 2023)
Article in Cancer Immunology, Immunotherapy (October 2023)
Article in Frontiers in Endocrinology (April 2023)